Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of anti-HER2 targeted therapies. However, patients can experience disease recurrence after curative intent and disease progression in the metastatic...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021-12-01
|
| coleção: | Breast |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S0960977621004379 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|